Purpose The results for individuals with repeated or metastatic sarcoma continues to be poor. without dose-limiting toxicity. At dosage level 3 (1 × 105/m2) and above we discovered HER2-CAR T cells 3 hours after infusion by quantitative polymerase string response in 14 of 16 sufferers. HER2-CAR T cells persisted for at least 6 weeks in… Continue reading Purpose The results for individuals with repeated or metastatic sarcoma continues